Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CDK12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD164 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METTL9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TTI1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYRM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GABPB1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LINC00996 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CELF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPLL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM50A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASSF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EOGT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCOLN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF93 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on